TickerFacts.

Marpai, Inc. (MRAI): Revenue

Annual figures by period end, from SEC filings.

$18.10M
Year ended 2025-12-31
$16.64M
Trailing 12 months to 2026-06-30
$37.16M2023-12-31: $37.16M2024-12-31: $28.17M2025-12-31: $18.10M$18.10M
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$18.10M-35.8%2026-03-25, From 2025-01-01
2024-12-31$28.17M-24.2%2026-03-25, From 2024-01-01
2023-12-31$37.16Mn/a2025-03-27, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Marpai, Inc. (MRAI)2025-12-31$18.10M-35.8%
Cryo Cell International Inc (CCEL)2025-11-30$31.57M-1.3%
Pacific Health Care Organization Inc (PFHO)2025-12-31$6.72M+10.7%
Charming Medical Ltd (MCTA)2026-03-31$4.81M-22.7%
Viemed Healthcare, Inc. (VMD)2025-12-31$270.28M+20.5%
Mangoceuticals, Inc. (MGRX)2025-12-31$456.0K-26.0%
BioRestorative Therapies, Inc. (BRTX)2025-12-31$359.7K-10.3%
Sotera Health Co (SHC)2025-12-31$1.16B+5.7%
Progyny, Inc. (PGNY)2025-12-31$1.29B+10.4%

Compare MRAI, CCEL, PFHO, MCTA side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗